Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03324243
Status:
WITHDRAWN
Last Update Posted:
2019-01-10
First Post:
2017-10-18
Brief Title:
A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With RelapsedRefractory FLT3-Mutated Acute Myeloid Leukemia
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-10-18
First Submit QC Date:
October 24 2017
Study First Post Date:
2017-10-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-08
Last Update Post Date:
2019-01-10
Last Update Post Date Type:
ACTUAL